Merck & Co Osake

Merck & Co P/CF

P/CF (Hinta-kassavirta-suhde) yhtiöstä Merck & Co (MRK) 4.8.2026 päivämäärällä on 18,29. Edellisenä vuonna P/CF (Hinta-kassavirta-suhde) oli 14,04 — muutos 30,33 % (korkeampi).

P/CF

18,29

YoY

30,33%

Viimeksi päivitetty:

P/CF (Hinta-kassavirta-suhde) yhtiöstä Merck & Co on 2026 18,29 . P/CF (Hinta-kassavirta-suhde) yhtiöstä Merck & Co oli 2025 14,04 . Se laskee 30,33% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Merck & Co Osakeanalyysi

Mitä Merck & Co tekee? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Merck & Co osakkeesta

Yhtiön Merck & Co P/CF (Hinta-kassavirta-suhde) on 18,29 vuonna 2026.

P/CF (Hinta-kassavirta-suhde) yhtiöstä Merck & Co muuttui arvosta 14,04 arvoon 18,29, mikä edustaa 30,33 % muutosta. Arvo on korkeampi kuin edellisenä vuonna.

Eurpoolissa voit löytää P/CF (Hinta-kassavirta-suhde) Merck & Co:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Hinta-kassavirta-suhde mittaa osakekurssia suhteessa operatiiviseen kassavirtaan per osake. Toisin kuin P/E-suhde, sitä on vaikeampi manipuloida, koska kassavirta on vähemmän altis kirjanpitomuutoksille.

P/CF = Osakekurssi / Operatiivinen kassavirta per osake

Arvioidakseen P/CF (Hinta-kassavirta-suhde):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja P/CF (Hinta-kassavirta-suhde):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata P/CF (Hinta-kassavirta-suhde):n Merck & Co alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Merck & Co

Kaikki tunnusluvut — Merck & Co